Legislation Clerk's Office Members Committees Meetings Home Senate
HR 1429 - House Ovarian Cancer Study Committee; create
Pelote, Dorothy B (149th) Stanley, Lanett (50th) Stanley, Pamela A (49th)
Burkhalter, Joseph Mark (41st) Ashe, Kathy B (46th) Hugley, Carolyn F (133rd)
Status Summary HC: Rules SC: FR: 03/22/00 LA: 03/22/00 H - Read 1st Time

First Reader Summary

A RESOLUTION creating the House Ovarian Cancer Study Committee; and for other purposes.

Page Numbers: 1 2

House Action Senate
3/22/00 Read 1st Time
Version by LC Number
As Introduced
LC 27 1224 As Introduced

HR 1429                                            LC 27 1224 
 
 
 
 
 
 
                             A RESOLUTION 
 
  1- 1  Creating the House Ovarian Cancer Study Committee; and for 
  1- 2  other purposes. 
 
  1- 3  WHEREAS, the American Cancer Society estimates that 
  1- 4  approximately 26,800 new cases of ovarian cancer were 
  1- 5  diagnosed in the United States in 1997, and an estimated 
  1- 6  14,200 women died from ovarian cancer in the United States 
  1- 7  during that year; and 
 
  1- 8  WHEREAS, ovarian cancer is the deadliest malignancy of the 
  1- 9  female reproductive system, in part because only about 24 
  1-10  percent of the cases are detected during the early stages of 
  1-11  the disease; and 
 
  1-12  WHEREAS, an estimated 300 Georgians die from ovarian cancer 
  1-13  annually; and 
 
  1-14  WHEREAS, the Pap test, which is an effective detector of 
  1-15  early cervical cancer, detects ovarian cancer only in the 
  1-16  later stages; and 
 
  1-17  WHEREAS, screening with sonograms and blood tests of women 
  1-18  who are high risks for developing ovarian cancer, such as 
  1-19  women with family histories of ovarian cancer or breast 
  1-20  cancer, would help to save lives by early diagnosis and 
  1-21  effective treatment; and 
 
  1-22  WHEREAS, other life saving programs include public education 
  1-23  campaigns, programs to alert doctors regarding early 
  1-24  symptoms, insurance coverage for screening high risk 
  1-25  populations, and increased research. 
 
  1-26  NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF 
  1-27  REPRESENTATIVES that there is created the House Ovarian 
  1-28  Cancer Study Committee to be composed of three members of 
  1-29  the House of Representatives to be appointed by the Speaker 
  1-30  of the House of Representatives.  The Speaker shall 
  1-31  designate a member of the committee as chairperson of the 
  1-32  committee.  The chairperson shall call all meetings of the 
  1-33  committee. 
 
  1-34  BE IT FURTHER RESOLVED that the committee shall undertake a 
  1-35  study of the conditions, needs, issues, and problems 
 
 
 
                                 -1- 
 
 
 
  2- 1  mentioned above or related thereto and recommend any actions 
  2- 2  or legislation which the committee deems necessary or 
  2- 3  appropriate.  The committee may conduct such meetings at 
  2- 4  such places and at such times as it may deem necessary or 
  2- 5  convenient to enable it to exercise fully and effectively 
  2- 6  its powers, perform its duties, and accomplish the 
  2- 7  objectives and purposes of this resolution.  The members of 
  2- 8  the committee shall receive the allowances authorized for 
  2- 9  legislative members of interim legislative committees but 
  2-10  shall receive the same for not more than five days unless 
  2-11  additional days are authorized.  The funds necessary to 
  2-12  carry out the provisions of this resolution shall come from 
  2-13  the funds appropriated to the House of Representatives. In 
  2-14  the event the committee makes a report of its findings and 
  2-15  recommendations, with suggestions for proposed legislation, 
  2-16  if any, such report shall be made on or before December 1, 
  2-17  2001. The committee shall stand abolished on December 1, 
  2-18  2001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                 -2- 

Clerk of the House
Robert E. Rivers, Jr., Clerk
Last Updated on 03/24/00